Business Description
Biovet JSC
ISIN : BG11BIPEAT11
Compare
Compare
Traded in other countries / regions
Description
Biovet JSC manufactures & markets medicated and nutritional feed additives, enzymes, bulk active substances & pharmaceuticals for animal productivity & health. It offers intermediates, active ingredients and medicines for human pharmaceutical industry.
Financial Strength
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 0.06 | |||||
Equity-to-Asset | 0.39 | |||||
Debt-to-Equity | 0.28 | |||||
Debt-to-EBITDA | 1.86 | |||||
Interest Coverage | 27.31 | |||||
Piotroski F-Score | 5/9 | |||||
Altman Z-Score | 1.02 | |||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 8.3 | |||||
3-Year EBITDA Growth Rate | 15.5 | |||||
3-Year EPS without NRI Growth Rate | 21.1 | |||||
3-Year FCF Growth Rate | 53.6 | |||||
3-Year Book Growth Rate | 13.8 |
Momentum Rank
| Name | Current | Vs Industry | Vs History |
|---|
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 0.59 | |||||
Quick Ratio | 0.12 | |||||
Days Inventory | 104.31 | |||||
Days Payable | 61.28 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History |
|---|
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 10.98 | |||||
Operating Margin % | 8.68 | |||||
Net Margin % | 7.52 | |||||
ROE % | 13.83 | |||||
ROA % | 5.66 | |||||
ROIC % | 11.38 | |||||
ROC (Joel Greenblatt) % | 11.13 | |||||
Years of Profitability over Past 10-Year | 8 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PE Ratio | 5.75 | |||||
PE Ratio without NRI | 5.75 | |||||
PEG Ratio | 0.21 | |||||
PS Ratio | 0.43 | |||||
PB Ratio | 0.75 | |||||
EV-to-EBIT | 6.73 | |||||
EV-to-EBITDA | 6.73 | |||||
EV-to-Revenue | 0.58 | |||||
Earnings Yield (Greenblatt) % | 14.86 | |||||
FCF Yield % | 2.9 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Biovet JSC Executives
DetailsGF Valueâ„¢
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil лв) | |||
| EPS (TTM) (лв) | 2.41 | ||
| Beta | - | ||
| 3-Year Sharpe Ratio | - | ||
| 3-Year Sortino Ratio | - | ||
| Volatility % | - | ||
| 14-Day RSI | - | ||
| 14-Day ATR (лв) | - | ||
| 20-Day SMA (лв) | - | ||
| 12-1 Month Momentum % | - | ||
| 52-Week Range (лв) | 0 - 0 | ||
| Shares Outstanding (Mil) | 6.78 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 5 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Biovet JSC Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Biovet JSC Stock Events
| Event | Date | Price (лв) | ||
|---|---|---|---|---|
| No Event Data | ||||
Biovet JSC Frequently Asked Questions
What is Biovet JSC(LTS:0III)'s stock price today?
The current price of LTS:0III is лв0.00. The 52 week high of LTS:0III is лв0.00 and 52 week low is лв0.00.
When is next earnings date of Biovet JSC(LTS:0III)?
The next earnings date of Biovet JSC(LTS:0III) is .
Does Biovet JSC(LTS:0III) pay dividends? If so, how much?
Biovet JSC(LTS:0III) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on Biovet JSC
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers